BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ampomah PB, Kong WT, Zharkova O, Chua SCJH, Perumal Samy R, Lim LHK. Annexins in Influenza Virus Replication and Pathogenesis. Front Pharmacol 2018;9:1282. [PMID: 30498445 DOI: 10.3389/fphar.2018.01282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Caccuri F, Bugatti A, Zani A, De Palma A, Di Silvestre D, Manocha E, Filippini F, Messali S, Chiodelli P, Campisi G, Fiorentini S, Facchetti F, Mauri P, Caruso A. SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells. Microorganisms 2021;9:1438. [PMID: 34361874 DOI: 10.3390/microorganisms9071438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Németh K, Petschner P, Pálóczi K, Fekete N, Pállinger É, Buzás EI, Tamási V. Chronic Exposure to the Food Additive tBHQ Modulates Expression of Genes Related to SARS-CoV-2 and Influenza Viruses. Life 2022;12:642. [DOI: 10.3390/life12050642] [Reference Citation Analysis]
3 Dolinski AC, Homola JJ, Jankowski MD, Robinson JD, Owen JC. Differential gene expression reveals host factors for viral shedding variation in mallards (Anas platyrhynchos) infected with low-pathogenic avian influenza virus. J Gen Virol 2022;103. [PMID: 35353676 DOI: 10.1099/jgv.0.001724] [Reference Citation Analysis]
4 Tan KS, Lim RL, Liu J, Ong HH, Tan VJ, Lim HF, Chung KF, Adcock IM, Chow VT, Wang Y. Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium. Front Cell Dev Biol 2020;8:99. [PMID: 32161756 DOI: 10.3389/fcell.2020.00099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
5 Magnani HN. Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection. Clin Appl Thromb Hemost 2021;27:1076029620977702. [PMID: 33539214 DOI: 10.1177/1076029620977702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Bonavita AG. Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis. Med Hypotheses 2020;145:110352. [PMID: 33129009 DOI: 10.1016/j.mehy.2020.110352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ma X, Zhang K, Luo Z, Nian X, Choudhury SKM, Zhu Z, Song R, Pei J, Huo Y, Li Y, Yang F, Cao W, Liu H, Liu X, Zheng H. FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication. J Virol 2022;:e0031722. [PMID: 35604142 DOI: 10.1128/jvi.00317-22] [Reference Citation Analysis]
8 Canacik O, Sabirli R, Altintas E, Karsli E, Karis D, Kaymaz B, Tukenmez Sabirli G, Kurt Ö, Koseler A. Annexin A1 as a potential prognostic biomarker for COVID-19 disease: Case-control study. Int J Clin Pract 2021;:e14606. [PMID: 34228870 DOI: 10.1111/ijcp.14606] [Reference Citation Analysis]
9 Rudraprasad D, Sushma MV, Rengan AK, Naik MN, Joseph J. Characterization and proteome profiling of extracellular vesicles in a murine model of Staphylococcus aureus endophthalmitis. Microbes and Infection 2022. [DOI: 10.1016/j.micinf.2022.105014] [Reference Citation Analysis]
10 Gargan S, Stevenson NJ. Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease. Viruses 2021;13:2165. [PMID: 34834972 DOI: 10.3390/v13112165] [Reference Citation Analysis]